Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction: new technologies for genetic and newborn screening.

M R Seashore1, C Walsh-Vockley

  • 1Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut.

The Yale Journal of Biology and Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.

Pediatrics·2001
Same author

New England Consortium: a model for medical evaluation of expanded newborn screening with tandem mass spectrometry.

Journal of inherited metabolic disease·2001
Same author

Genetic screening and the pediatrician.

Pediatric annals·2000
Same author

Universal screening for congenital hearing loss.

Pediatric annals·2000
Same author

p73 mutations are not detected in sporadic and hereditary breast cancer.

Breast cancer research and treatment·2000
Same author

Glucose transporter type 1 deficiency: a study of two cases with video-EEG.

European journal of pediatrics·1999
Same journal

Chrysoeriol-Mediated Neuroprotection in Parkinson's Disease in Mice: Targeting Apoptosis, α-Synuclein Accumulation, and Functional Recovery.

The Yale journal of biology and medicine·2026
Same journal

Musicality is Preserved in Neurodegeneration.

The Yale journal of biology and medicine·2026
Same journal

Burden of Neurological Disorders in Resource-Limited Settings: Lessons from Pakistan for Global Neurology.

The Yale journal of biology and medicine·2026
Same journal

Comparative Analysis of Prenatal Stress Models: Placental and Neurodevelopmental Outcomes in Mice.

The Yale journal of biology and medicine·2026
Same journal

Computational Investigation of Flavonoid-Associated Molecular Pathways in Astrogliosis Modulation.

The Yale journal of biology and medicine·2026
Same journal

Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and <i>In Silico</i> Analysis.

The Yale journal of biology and medicine·2026
See all related articles

Newborn screening for inherited disorders prevents serious health issues. Advances in genetic screening will expand to populations, necessitating policy discussions on financial, legal, and ethical implications.

Area of Science:

  • Medical Genetics
  • Public Health Policy
  • Bioethics

Background:

  • Newborn screening for inherited metabolic disorders has successfully prevented severe health outcomes for over 20 years.
  • Technological advancements are expanding screening capabilities beyond newborns to broader population genetic risk assessment.

Purpose of the Study:

  • To address the financial, legal, and ethical considerations arising from expanded genetic screening.
  • To inform the development of public policies for effective implementation of genetic screening technologies.

Main Methods:

  • The study is based on discussions and findings from a conference.
  • The conference convened health care practitioners, health policy planners, and public health professionals.

Related Experiment Videos

Main Results:

  • The conference highlighted the critical need to consider financial, legal, and ethical issues.
  • Effective public policy development is essential to maximize the benefits of advanced screening techniques.

Conclusions:

  • Expanding genetic screening necessitates proactive policy development to manage associated challenges.
  • Integrating financial, legal, and ethical frameworks is crucial for the responsible advancement of population-level genetic risk assessment.